NCT03371550View on ClinicalTrials.gov

A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

August 5, 2004

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2011

Conditions
Locally Advanced Non-small Cell Lung Cancer
Interventions
DRUG

Docetaxel

Induction chemotherapy

RADIATION

concomitant radiotherapy

Pulmonary and mediastinal radiotherapy

DRUG

Cisplatin

Induction chemotherapy

All Listed Sponsors
lead

Centre Antoine Lacassagne

OTHER

NCT03371550 - A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy | Biotech Hunter | Biotech Hunter